Bulletin
Investor Alert

Syneos Health Inc. Cl A

NAS: SYNH

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Oct 18, 2019, 4:44 p.m.

/zigman2/quotes/207981284/composite

$

55.03

Change

0.00 0.00%

Volume

Volume 24,435

Quotes are delayed by 20 min

/zigman2/quotes/207981284/composite

Previous close

$ 55.37

$ 55.03

Change

-0.34 -0.61%

Day low

Day high

$54.62

$55.68

Open

52 week low

52 week high

$36.27

$56.34

Open

Company Description

Provides outsourced clinical development and commercialization services to biopharmaceutical companies

Officers and Executives

Name Age Officer Since Title
Mr. Alistair John Macdonald 49 2010 Chief Executive Officer & Director
Mr. Jason Michael Meggs 43 2018 Chief Financial Officer & Executive Vice President
Mr. Purvesh Patel - 2018 Chief Administrative Officer & Executive VP
Mr. Mark Dmytruk - - Executive VP-Corporate Strategy & Development
Mr. Neil Ferguson - - Chief Business Officer

Insider Actions

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
08/01/2019 Alistair John Macdonald
Chief Executive Officer; Director
4,178   Derivative/Non-derivative trans. at $48.99 per share. 204,680
07/29/2019 Jason Michael Meggs
Chief Financial Officer
157   Derivative/Non-derivative trans. at $49.33 per share. 7,744
07/01/2019 Alistair John Macdonald
Chief Executive Officer; Director
1,022   Derivative/Non-derivative trans. at $51.46 per share. 52,592
05/24/2019 Thomas H. Lee Partners LP
Director
4,122   Award at $0 per share. 0
05/24/2019 Thomas H. Lee Partners LP
Director
4,122   Award at $0 per share. 0
05/24/2019 Thomas H. Lee Partners LP
Director
4,122   Award at $0 per share. 0
05/24/2019 Thomas H. Lee Partners LP
Director
4,122   Award at $0 per share. 0
05/24/2019 Kenneth F. Meyers
Director
4,122   Award at $42.45 per share. 174,978
05/24/2019 Matthew E. Monaghan
Director
4,122   Award at $42.45 per share. 174,978
05/24/2019 William E. Klitgaard
Director
4,122   Award at $42.45 per share. 174,978
05/24/2019 Linda S. Harty
Director
4,122   Award at $42.45 per share. 174,978
05/24/2019 John M. Dineen
Director
4,122   Award at $42.45 per share. 174,978
04/30/2019 Thomas H. Lee Partners LP
Director
5,504,340   238,392,965
02/15/2019 Alistair John Macdonald
Chief Executive Officer; Director
12,451   Derivative/Non-derivative trans. at $54.74 per share. 681,567
02/15/2019 Jason Michael Meggs
Chief Financial Officer
2,617   Derivative/Non-derivative trans. at $54.74 per share. 143,254
02/15/2019 Michelle Keefe
Pres., Commercial Solutions
1,925   Derivative/Non-derivative trans. at $54.74 per share. 105,374
02/13/2019 Alistair John Macdonald
Chief Executive Officer; Director
8,143   Disposition at $53 per share. 431,579
02/13/2019 Alistair John Macdonald
Chief Executive Officer; Director
8,143   Derivative/Non-derivative trans. at $8.45 per share. 68,808
02/05/2019 Alistair John Macdonald
Chief Executive Officer; Director
6,697   Disposition at $53.04 per share. 355,208
02/05/2019 Alistair John Macdonald
Chief Executive Officer; Director
6,697   Derivative/Non-derivative trans. at $8.45 per share. 56,589
01/28/2019 Alistair John Macdonald
Chief Executive Officer; Director
3,387   Derivative/Non-derivative trans. at $50.25 per share. 170,196
01/28/2019 Jason Michael Meggs
Chief Financial Officer
448   Derivative/Non-derivative trans. at $50.25 per share. 22,512
01/22/2019 Alistair John Macdonald
Chief Executive Officer; Director
6,463   Derivative/Non-derivative trans. at $48.79 per share. 315,329
01/22/2019 Jason Michael Meggs
Chief Financial Officer
152   Derivative/Non-derivative trans. at $48.79 per share. 7,416
/news/latest/company/us/synh

MarketWatch News on SYNH

  1. Syneos Health stock price target raised to $57 vs.s $53.50 at UBS, 'overhang removed' after SEC probe

    10:29 a.m. Aug. 29, 2019

    - Ciara Linnane

  2. Syneos Health downgraded to neutral from buy at UBS

    10:12 a.m. March 20, 2019

    - Tomi Kilgore

  3. Syneos Health started at buy with $60 stock price target at UBS

    3:14 p.m. Oct. 9, 2018

    - Tomi Kilgore

  4. Elliott Associates Thinks It Can Make Nielsen Click

    3:14 p.m. Aug. 20, 2018

    - Barron's Online

  5. Here are Wall Street’s 19 favorite mid-cap stocks for 2018

    8:30 a.m. Dec. 8, 2017

    - Philip van Doorn

  6. Healthcare Stocks: Calm After The Storm?

    11:16 a.m. Aug. 1, 2017

    - Barrons Blogs

  7. INC Research stock price target raised to $67 from $51 at Raymond James

    8:23 a.m. June 8, 2017

    - Tomi Kilgore

  8. INC Research upgraded to overweight from sector weight at KeyBanc Capital

    7:25 a.m. June 5, 2017

    - Tomi Kilgore

  9. INC Research stock price target raised to $67 vs. $48 at SunTrust Robinson Humphrey

    7:31 a.m. May 31, 2017

    - Ciara Linnane

  10. INC Research upgraded to buy at SunTrust Robinson Humphrey

    7:30 a.m. May 31, 2017

    - Ciara Linnane

  11. Starboard Value Sees Possible Sale of Parexel

    1:23 a.m. May 20, 2017

    - Barron's Online

  12. INC Research upgraded to outperform from neutral at RW Baird

    7:29 a.m. May 11, 2017

    - Tomi Kilgore

  13. Stock winners and losers — Nvidia rockets and Yelp tumbles

    11:33 a.m. May 10, 2017

    - Philip van Doorn

  14. Pain may be in store for the S&P 500, says Goldman

    8:32 a.m. Sept. 13, 2016

    - Ryan Vlastelica

  15. Zika Shares Don’t Look Like a Bargain

    1:59 a.m. Aug. 13, 2016

    - Barron's Online

  16. Loading more headlines...
/news/nonmarketwatch/company/us/synh

Other News on SYNH

  1. SYNH vs. CERN: Which Stock Is the Better Value Option?

    9:30 a.m. Oct. 17, 2019

    - Zacks.com

  2. QIAGEN (QGEN) Launches QIAseq FastSelect Technology Kits

    8:31 a.m. Oct. 15, 2019

    - Zacks.com

  3. Smith & Nephew's (SNN) STITCH Study Outcome Encouraging

    10:07 a.m. Oct. 10, 2019

    - Zacks.com

  4. SYNH vs. NXGN: Which Stock Should Value Investors Buy Now?

    9:30 a.m. Sept. 30, 2019

    - Zacks.com

  5. SYNH or CERN: Which Is the Better Value Stock Right Now?

    9:40 a.m. Aug. 27, 2019

    - Zacks.com

  6. 3 Reasons Growth Investors Will Love Syneos Health (SYNH)

    8:45 a.m. Aug. 16, 2019

    - Zacks.com

  7. Loading more headlines...

At a Glance

Syneos Health, Inc.

1030 Sync Street

Morrisville, North Carolina 27560-5468

Phone

1 9198769300

Industry

Biotechnology

Sector

Health Care/Life Sciences

Fiscal Year-end

-

Revenue

N/A

Net Income

N/A

Employees

-

/news/pressrelease/company/us/synh

Press Releases on SYNH

  1. Altasciences Welcomes Dr. Beatrice Setnik as Chief Scientific Officer

    8:29 a.m. Aug. 7, 2019

    - BusinessWire - BZX

  2. Syneos Health Reports Second Quarter 2019 Results

    6:24 a.m. Aug. 6, 2019

    - GlobeNewswire

  3. Syneos Health Reports Second Quarter 2019 Results

    6:14 a.m. Aug. 6, 2019

    - GlobeNewswire

  4. Emerald Health Therapeutics Appoints Chief Executive Officer

    7:01 a.m. July 30, 2019

    - GlobeNewswire

  5. Emerald Health Therapeutics Appoints Chief Executive Officer

    7:01 a.m. July 30, 2019

    - GlobeNewswire

  6. Loading more headlines...
Trending Tickers
  • /quotes/zigman/17636479/composite VUZI+15.60%
  • /quotes/zigman/237947/composite JCP-5.83%
  • /quotes/zigman/59392505/composite NUGT-2.93%
  • /quotes/zigman/59386294/composite JNUG-5.94%
  • /quotes/zigman/65801738/composite TLT+1.11%
X
Powered by StockTwits
Link to MarketWatch's Slice.